Propoxur (carbamate) poisoning: treatment to reduce mortality, morbidity, and preserve quality of life
Give high-dose atropine immediately, secure the airway early, decontaminate, and treat seizures with benzodiazepines; avoid succinylcholine/mivacurium; consider pralidoxime only if organophosphate exposure is possible or class is unknown. 1
Identify life-threatening cholinergic toxicity (act without delay)
- Clues: bronchorrhea, bronchospasm, hypoxia, bradycardia/hypotension, copious secretions, miosis, vomiting/diarrhea, weakness/fasciculations, seizures.
- Propoxur is a carbamate AChE inhibitor; rapid treatment prevents respiratory failure and death. 1
Immediate actions (in order of impact on survival)
- PPE and decontamination
- Don PPE; remove contaminated clothes, copious soap-and-water irrigation of skin/hair. Prevents continued absorption and staff exposure. 1
- Airway and breathing
- Intubate early for respiratory distress, inability to clear secretions, hypoxia, or impending fatigue. Use non–cholinesterase-metabolized paralytics; avoid succinylcholine and mivacurium. 1
- Atropine (life-saving, give now)
- Adult initial 1–2 mg IV; double every 5 minutes until “atropinization”: dry lungs on auscultation, HR >80/min, SBP >80 mm Hg. Then infusion at 10%–20% of total loading dose per hour (up to ~2 mg/h; titrate to secretions and vitals). Pediatric: 0.02 mg/kg with same doubling strategy. High cumulative doses are often required. 1
- Seizure and agitation control
- Give benzodiazepines (diazepam or midazolam). This reduces CNS morbidity and supports ventilation. Avoid flumazenil. 1
Oxime (pralidoxime) use
- Carbamates dissociate spontaneously from AChE; evidence is insufficient for or against oximes in pure carbamate poisoning. Do NOT delay atropine or airway. 1
- If the agent is unknown or mixed with organophosphate is possible, do not withhold pralidoxime: adult 1–2 g IV, then 400–600 mg/h infusion (peds 20–50 mg/kg load, then 10–20 mg/kg/h). 1
- If reliably confirmed isolated propoxur exposure with good atropinization and clinical improvement, routine oxime is not required. 1
Monitoring and supportive care
- Continuous pulse oximetry, cardiac monitoring; frequent lung auscultation for recurrent secretions.
- Treat hypotension with fluids; vasopressors as needed after adequate atropine and oxygenation.
- Reassess atropine infusion frequently; up-titrate if bronchorrhea/bradycardia recur. 1
- Consult a regional poison center early. 1
Pitfalls and how to avoid them
- Under-dosing atropine: titrate to clinical endpoints (dry lungs, adequate HR/BP), not to a fixed dose. This is the key determinant of survival. 1
- Delayed airway control: intubate early in severe secretions/bronchospasm; avoid succinylcholine/mivacurium. 1
- Withholding oximes when the class is unknown: give pralidoxime if uncertainty exists. 1
- Neglecting decontamination/PPE: prevents ongoing absorption and secondary exposure. 1
- Inadequate seizure control: use benzodiazepines promptly. 1
Evidence strength and nuances
- The 2023 AHA guideline provides Class I recommendations (highest) for immediate atropine, early intubation, benzodiazepines, PPE, and dermal decontamination in organophosphate/carbamate poisoning; succinylcholine/mivacurium are Class III (no benefit/harm). Pralidoxime is Class 2a for organophosphates and should not be withheld when poison class is unknown; evidence is insufficient to recommend for/against oximes in pure carbamate poisoning. These are the most recent, high-quality, practice-directing recommendations prioritizing survival and QOL. 1